Principal Medical Director Pandemic Influenza

Principal Medical Director Pandemic Influenza

F. Hoffmann-La Roche AG

Basel, Switzerland

We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.

That is why we come to work each day. We commit ourselves to scientific rigour, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.

We are proud of who we are, what we do, and how we do it. We are many, working as one across functions, across companies, and across the world.

We are Roche.

Objectives and Scope of pIMD/pISD Position:

- pIMD/ISD is the core PDMA role responsible for the development and execution medical affairs strategy in pandemic influenza including insights strategy, evidence generation strategy and communication strategy based on key insights and perspectives from multiple stakeholders

- Responsible for external stakeholders mapping and maintains an oversight of stakeholder engagement, incl. Therapeutic Area Experts and non-HCP key stakeholders

- pIMD/ISD provides medical/clinical expertise and input into the development of market access, brand and lifecycle strategies for influenza

- Stays abreast of internal and external developments, trends and other dynamics relevant for the assigned Disease Area to maintain a fully current view and perspectives of external influences

Summary of Main Responsibilities

Medical Strategy:

- Provides scientific expertise and leads the development and execution of the medical affairs pandemic influenza strategy and collaborates with public policy and pandemic business lead on overall pandemic strategy

Insights Generation:

- Leads the integrated insights strategy, which includes planning, organizing and interpreting insights from a broad range of customers and internal and external data sources to inform pandemic influenza strategies

Evidence Generation Strategy:

- Identifies and leads evidence generation strategy to address potential data gaps for baloxavir in pandemic influenza

External Collaborations:

- Responsible for Therapeutic Area Expert and non-HCP key stakeholder engagement strategy for pandemic influenza

Communication Strategy:

- Leads innovation in and development of education on influenza, antiviral treatment in general and in particular for baloxavir for key pandemic stakeholders incl. governmental and WHO Stakeholders

Summary of Extended Responsibilities

Execution of Evidence Generation Activities:

- Conducts review and approval of investigator initiated studies (IIS) and supported study proposals

- Reviews affiliate study synopses and signs off affiliate studies

- As appropriate, provides medical expertise and scientific data to support Regulatory, Drug Safety, Health Economics and Public Policy strategy and documents

Medical Education and Congress Activities:

- Contributes to the medical education needs assessments

- Accountable for the medical content of the medical education activities and publications related to pandemic influenza in collaboration with the SCD/SCL

- May present relevant data at congress events (e.g. affiliate briefings) and provide medical education to internal stakeholders

- Signs off medical education materials, Q&A and other documents for internal distribution and/or for external use (applicable for Senior/Principal IMD)

- Provides guidance to other GMT members on how to translate complex scientific/medical information into lay terms (e.g. patient materials etc.)

Digital health solutions:

- Collaborates with digital health team and other relevant stakeholders to define the strategic needs and implement digital health solutions in medical strategy development and execution

Promotional materials:

- Accountable for accurate and balanced medical information

- Reviews and approves (sign off) promotional materials (applicable for Senior/Principal IMD)

Advisory boards:

- Provides input on the advisory board plan for the assigned product(s)/DA

- Responsible for the medical scientific robustness of the information presented and for advice seeking questions

- Responsible for aligning advisory board advice requests with all internal and external stakeholders, such as GDT, LCT and advisors, in collaboration with the ISD

- Leads and may present the medical/scientific aspects of assigned product(s) at the advisory board meetings

Budget:

- Responsible for the budget oversight of the respective area and activities in close collaboration with the GMTL and the Project Manager

Compliance:

- Responsible for acting in line with legal, regulatory and company standards and codes of practice

- Completes all required training modules as priority

Cross-functional collaboration:

- Close colloaboration with other functions within PDMA

- Collabaration with relevant internal functions beyond PDMA

Job level:

- Principal IMD: Acts as an ambassador for the DA, both within PDMA and beyond. Is typically assigned to the most complex and strategically critical projects and/or evidence generation programs in the relevant DA. Drives innovation (incl. implementation of new methodologies, digital care solutions) and cross-functional collaborations

Professional and Technical Requirements

- MD or virologist well known among influenza experts in academia and/or governments and WHO with strong publication background in influenza (antivirals or vaccines) or virology.

- Industry experience in influenza e.g. vaccines is a plus

Technical Competencies:

- High ethical standards
- Ability to demonstrate Roche Values and Leadership Commitments
- Strategic agility and decision-making ability.
- Functional competencies, including but not limited to organization, prioritization and planning skills, negotiation skills, communication & presentation skills
- Ability to operate successfully in a matrix environment with shared accountability and responsibilities
- Ability to work across multiple cultures and countries

Experience, Skills, Knowledge

- Relevant clinical and scientific expertise and knowledge in influenza
- Good understanding of drug development process and related regulatory requirements
- Previous experience with launch of influenza antivirals or vaccines is a plus
- Proven expertise with a wide range of data and information (e.g. scientific, clinical and regulatory)
- Experience in the principles of data analysis, interpretation and assessing clinical relevance
- Experience of partnership with TAEs and external organizations is strongly preferred
- Good understanding of business context, incl. access evidence requirements and external value/decision-making drivers is preferred
- Fluency in written and spoken English

Roche is an equal opportunity employer.

Please apply via recruiter’s website.

Favorite